Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dementia01:30

Dementia

113
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
113

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

White matter integrity is associated with cognition and amyloid burden in older adult Koreans along the Alzheimer's disease continuum.

medRxiv : the preprint server for health sciences·2023
Same author

Consistency of Graph Theoretical Measurements of Alzheimer's Disease Fiber Density Connectomes Across Multiple Parcellation Scales.

Proceedings. IEEE International Conference on Bioinformatics and Biomedicine·2023
Same author

Social enrichment on the job: Complex work with people improves episodic memory, promotes brain reserve, and reduces the risk of dementia.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2023
Same author

Novel <i>CYP1B1-RMDN2</i> Alzheimer's disease locus identified by genome-wide association analysis of cerebral tau deposition on PET.

medRxiv : the preprint server for health sciences·2023
Same author

Aberrant GAP43 Gene Expression Is Alzheimer Disease Pathology-Specific.

Annals of neurology·2023
Same author

Integrative analysis of multi-omics and imaging data with incorporation of biological information via structural Bayesian factor analysis.

Briefings in bioinformatics·2023
Same journal

AMD-Mamba: A Phenotype-Aware Multi-modal Framework for Robust AMD Prognosis.

Machine learning in medical imaging. MLMI (Workshop)·2026
Same journal

Pseudo-Rendering for Resolution and Topology-Invariant Cortical Parcellation.

Machine learning in medical imaging. MLMI (Workshop)·2025
Same journal

Probabilistic 3D Correspondence Prediction from Sparse Unsegmented Images.

Machine learning in medical imaging. MLMI (Workshop)·2024
Same journal

Privacy-preserving Federated Brain Tumour Segmentation.

Machine learning in medical imaging. MLMI (Workshop)·2024
Same journal

Robust Unsupervised Super-Resolution of Infant MRI via Dual-Modal Deep Image Prior.

Machine learning in medical imaging. MLMI (Workshop)·2024
Same journal

MoViT: Memorizing Vision Transformers for Medical Image Analysis.

Machine learning in medical imaging. MLMI (Workshop)·2024
See all related articles

Related Experiment Video

Updated: Jul 1, 2025

Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.0K

Class-Balanced Deep Learning with Adaptive Vector Scaling Loss for Dementia Stage Detection.

Boning Tong1, Zhuoping Zhou1, Davoud Ataee Tarzanagh1

  • 1University of Pennsylvania, Philadelphia, PA 19104, USA.

Machine Learning in Medical Imaging. MLMI (Workshop)
|March 11, 2024
PubMed
Summary
This summary is machine-generated.

A new method, VS-Opt-Net, improves early Alzheimer's disease detection by enhancing machine learning models. It effectively balances datasets, leading to more accurate classification of cognitive normal, mild cognitive impairment, and Alzheimer's disease stages.

Keywords:
Alzheimer’s DiseaseClass-Balanced Deep LearningHyperparameter OptimizationMild Cognitive ImpairmentNeuroimaging

More Related Videos

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.5K
Author Spotlight: Enhancement of Salient Object Detection for Smart Grid Applications
03:31

Author Spotlight: Enhancement of Salient Object Detection for Smart Grid Applications

Published on: December 15, 2023

533

Related Experiment Videos

Last Updated: Jul 1, 2025

Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.0K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.5K
Author Spotlight: Enhancement of Salient Object Detection for Smart Grid Applications
03:31

Author Spotlight: Enhancement of Salient Object Detection for Smart Grid Applications

Published on: December 15, 2023

533

Area of Science:

  • Neuroscience
  • Machine Learning
  • Medical Imaging

Background:

  • Alzheimer's disease (AD) causes irreversible cognitive decline, with Mild Cognitive Impairment (MCI) as a precursor.
  • Early detection of AD and related dementias is critical for intervention and slowing disease progression.
  • Class imbalance in machine learning models for cognitive states (CN, MCI, AD) necessitates balanced accuracy metrics.

Purpose of the Study:

  • To introduce VS-Opt-Net, a novel method combining vector-scaling (VS) loss and Bayesian optimization within the STREAMLINE pipeline.
  • To enhance the performance and balanced accuracy of machine learning models for classifying cognitive normal (CN), Mild Cognitive Impairment (MCI), and Alzheimer's disease (AD) subjects.
  • To address class imbalance and improve generalization in deep network training for dementia detection.

Main Methods:

  • Utilized MRI-based brain regional measurements as features for binary classifications (CN vs MCI, AD vs MCI).
  • Incorporated the vector-scaling (VS) loss function into the STREAMLINE machine learning pipeline.
  • Employed Bayesian optimization for hyperparameter tuning of both the VS loss function and the deep learning model.
  • Compared the balanced accuracy of VS-Opt-Net against other class-balanced machine learning models and loss functions.

Main Results:

  • Hyperparameter optimization using Bayesian methods significantly improved the balanced accuracy of the deep neural network with VS loss.
  • The VS-Opt-Net model demonstrated superior performance compared to other models on the Alzheimer's disease dataset.
  • Feature importance analysis revealed VS-Opt-Net's capability to identify key biomarker differences across dementia stages.

Conclusions:

  • VS-Opt-Net effectively enhances model performance and balanced accuracy in classifying cognitive states, particularly for imbalanced datasets.
  • The proposed method, leveraging VS loss and Bayesian optimization, offers a promising approach for early Alzheimer's disease detection using neuroimaging data.
  • VS-Opt-Net aids in understanding neurobiological distinctions between different stages of cognitive impairment and dementia.